Abstract
Rationale
Previous studies on the effects of ecstasy on neuropsychological performance have often recruited small sample sizes.
Objectives
The present study was conducted to validate previous findings regarding the effects of ecstasy consumption on neuropsychological performance.
Method
A comprehensive neuropsychological investigation was conducted in 100 abstinent ecstasy users and 100 matched non-user counterparts on standardized measures of working memory, verbal and non-verbal memory, verbal and figural fluency, and selective and switching attention.
Results
Abstinent ecstasy users were impaired on verbal and non-verbal memory, complex attention, and verbal fluency, but not on working memory, relative to their non-user counterparts. Of particular interest was the fact that abstinent ecstasy users performed better on figural fluency relative to their non-user counterparts. In addition, only cumulative ecstasy consumption correlated with neuropsychological performances among abstinent ecstasy users. Canonical discriminant analysis yielded verbal and visual memory, switching attention, and verbal fluency as potential core neuropsychological variables for differentiating abstinent ecstasy users from non-users. Levels of depression and general non-verbal intelligence, as measured by the Beck Depression Inventory and the test of non-verbal Intelligence, respectively, were not likely to affect these findings, since these measures were matched between ecstasy users and non-users.
Conclusions
These findings suggest that previous ecstasy consumption can affect a wide range of neuropsychological performance, though figural fluency may be subsequently enhanced as a result of the phenomenon of “cortical disinhibition.” Furthermore, measures of verbal and visual memory, switching attention, and verbal fluency may be particularly useful for differentiating abstinent ecstasy users from non-users.
Similar content being viewed by others
References
Aguirre N, Frechilla D, Garcia-Osta A, Lasheras B, Del Rio J (1997) Differential regulation by methylenedioxy-methamphetamine of 5-hydroxytryptamine 1A receptor density and mRNA expression in rat hippocampus, frontal cortex, and brainstem. J Neurochem 68:1099–1105
Akshoomoff N, Delis DC, Kiefner MG (1989) Block constructions of chronic alcoholic and unilateral brain-damaged patients: a test of the right hemisphere vulnerability hypothesis of alcoholism. Arch Clin Neuropsychol 4:275–281
Battaglia G, Yeh SY, O’Hearn E et al. (1987) 3,4-methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantifications of neurodegeneration by measurement of [3H] paroxetine-labelled serotonin uptake sites. J Pharmacol Exp Ther 242:911–916
Battaglia G, Yeh SY, De Souza EB (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29:269–274
Beck AT (1987) Beck depression inventory. Psychological Corporation, Tex.
Benton AL, Hamsher K, Varney NR, Spreen O (1983) Contributions to neuropsychological assessment. Oxford University Press, New York
Bhattachary S, Powell JH (2001) Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or “ecstasy”: evidence for cognitive impairment. Psychol Med 31:647–658
Bolla KI, McCann UD, Ricaurte GA (1998) Memory impairment in abstinent MDMA (“ecstasy”) users. Neurology 51:1532–1537
Bowden SC (1988) Learning in young alcoholics. J Clin Exp Neuropsychol 10:157–168
Braff DL, Silverton L, Saccuzzo DP, Janowsky DS (1981) Impaired speed of visual information processing in marijuana intoxication. Am J Psychiatry 138:613–617
Brown L, Sherbenou RJ, Johnsen SK (1997) Test of non-verbal intelligence: a language-free measure of cognitive ability, 3rd edn. Pro-ed, Tex.
Chang L, Grob CS, Ernst T, Itti L, Mishkin FS, Jose-Melchor R, Poland RE (2000) Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study. Psychiatry Res 98:15–28
Cheng W-C, Poon N-L, Chan M-F (2003) Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong. J Forens Sci 48(6):1249–1259
Croft RJ, Mackay AJ, Mills ATD, Gruzelier JGH (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153:373–379
Curran HV, Travill RA (1997) Mood and cognitive effects of ±3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”): week-end “high” followed by mid-week low. Addiction 92:821–831
D’Elia LF, Satz P, Uchiyama CL, White T (1996) Color trails test: professional manual. Psychological Assessment Resources, Fla.
Dafters RI, Duffy F, O’Donnell PJ, Bouquet C (1999) Level of use of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in human correlates with EEG power and coherence. Psychopharmacology 145:82–90
Darley CF, Tinklenberg JR, Roth WT, Holliste LE, Atkinson RC (1973) Influence of marijuana on storage and retrieval processes in memory. Mem Cogn 1:196–200
De Renzi E, Faglioni P, Nichelli P, Pignattari L (1984) Intellectual and memory impairment in moderate and heavy drinkers. Cortex 20:525–533
Fischer C, Hatzidimitriou G, Wlos J, Katz J, Ricaurte G (1995) Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). J Neurosci 15:5426–5485
Gamma A, Buck A, Berthold T, Hell D, Vollenweider FX (2000) 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H215O]-PET in healthy humans. Neuropsychopharmacology 23:388–395
Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert H-J, Fimm B, Sass H (2000) Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68:719–725
Grant I (1987) Alcohol and the brain: neuropsychological correlates. J Consult Clin Psychol 55:310–324
Grant I, Adams KM, Carlin AS et al. (1978a) The collaborative neuropsychological study of polydrug users. Arch Gen Psychiatry 35:1063–1064
Grant I, Adams KM, Carlin AS et al. (1978b) Neuropsychological effects of polydrug abuse. In: Wesson DR, Carlin AS, Adams KM, Beschner G (eds) Polydrug abuse. Academic, New York
Hatzidimitriou G, McCann DU, Ricaurte G (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with ±3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19:5096–5107
Kapur N, Butters N (1977) Visuoperceptive impairments in long-term alcoholics and alcoholics with Korsakoff’s psychosis. J Stud Alcohol 38:2025–2035
Lee TMC, Chan CCH (2000a) Are trail making and color trails tests of equivalent constructs? J Clin Exp Neuropsychol 22:529–534
Lee TMC, Chan CCH (2000b) Stroop interference in Chinese and English. J Clin Exp Neuropsychol 22:465–471
Lee TMC, Yip JTH, Jones-Gotman M (2002a) Memory deficits after resection from left or right anterior temporal lobe in humans: a meta-analytic review. Epilepsia 43:283–291
Lee TMC, Yuen KSL, Chan CCH (2002b) Normative data for neuropsychological measures of fluency, attention, and memory measures for Hong Kong Chinese. J Clin Exp Neuropsychol 24:615–632
Lezak MD (1979) Recovery of memory and learning functions following traumatic brain injury. Cortex 15:63–70
London ED, Ernst M, Grant S, Bonson K, Weinstein A (2000) Orbitofrontal cortex and human drug abuse: functional imaging. Cereb Cortex 10:334–342
MacVane J, Butters N, Montgomery K, Farber J (1982) Cognitive functioning in men social drinkers. J Stud Alcohol 43:81–95
Majdan A, Sziklas V, Jones-Gotman M (1996) Performance of healthy subjects and patients with resection from the anterior temporal lobe on matched tests of verbal and visuoperceptual learning. J Clin Exp Neuropsychol 18:416–430
McCaffrey RJ, Krahula MM, Heimberg RG et al. (1988) A comparison of the Trail Making Test, Symbol Digit Modalities Test, and the Hooper Visual Organization Test in an inpatient substance abuse population. Arch Clin Neuropsychol 3:181–187
McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994) Serotonin neurotoxicity after (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”): a controlled study in humans. Neuropsychopharmacology 10:129–138
McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998) Positron emission tomographic evidence of toxic effect of MDMA (“ecstasy”) on brain serotonin neurons in human beings. Lancet 352:1433–1437
McCann UD, Mertl M, Eligulashvili V, Ricaurte GA (1999) Cognitive performance in (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study. Psychopharmacology 143:417–425
Mittenberg W, Motta S (1993) Effects of chronic cocaine abuse on memory and learning. Arch Clin Neuropsychol 8:477–483
Molliver ME, Berger UV, Mamounas LA et al. (1990) Neurotoxicity of MDMA and related compounds. Ann N Y Acad Sci 600:640–646
Morgan MJ (1998) Recreational use of “ecstasy” (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19:252–264
Morgan MJ (1999) Memory deficits associated with recreational use of “ecstasy” (MDMA). Psychopharmacology 141:30–36
Morgan MJ (2000) Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology 152:230–248
O’Hearn EG, Battaglia G, De Souza EB et al. (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci 8:2788–2803
Obrocki J, Buchert R, Väterlein O, Thomasius R, Beyer W (1999) Ecstasy—long term effects on the human central nervous system revealed by positron emission tomography. Br J Psychiatry 175:186–188
Parker ES, Noble EP (1977) Alcohol consumption and cognitive functioning in social drinkers. J Stud Alcohol 38:1224–1232
Parrott AC (2000) Human research on MDMA (3,4-methylene-dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change. Neuropsychobiology 42:17–24
Parrott AC (2001) Human psychopharmacology of ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol 16:557–577
Parrott AC, Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology 139:261–268
Parsons OA, Farr SP (1981) The neuropsychology of alcohol and drug use. In: Filskov SB, Boll TJ (eds) Handbook of clinical neuropsychology. Wiley-Interscience, New York
Regard M (1981) Cognitive rigidity and flexibility: a neuropsychological study. Unpublished PhD dissertation, University of Victoria, British Columbia
Reneman L, Booij J, Schmand B, van den Brink W, Gunning B (2000) Memory disturbances in “ecstasy” users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology 148:322–324
Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W (2001) Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358 (9296):1864–1869
Rey A (1959) Sollicitation de la mémoire de fixation par des mots et des objets presentés simultanément. Arch Psychol 37:126–139
Ricaurte GA, Bryan G, Strauss L et al (1985) Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 22:986–988
Ricaurte GA, DeLanney LE, Irwin I, Langston JW (1988a) Toxic effects of 3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res 446:165–168
Ricaurte GA, Forno LS, Wilson MA et al. (1988b) MDMA selectively damages central serotonergic neurons in the primate. JAMA 260:51–55
Ricaurte GA, Martello AL, Katz JL et al. (1992) Lasting effects of MDMA on central serontonergic neurons in nonhuman primates: neurochemical observations. J Pharmacol Exp Ther 261:616–622
Rodgers J (2000) Cognitive performance amongst recreational users of “ecstasy.” Psychopharmacology 151:19–24
Ruff RM (1996) Ruff figural fluency test: professional manual. Psychological Assessment Resources, Fla.
Ruff RM, Allen CC, Farrow CE, Niemann H, Wylie T (1994) Figural fluency: differential impairment in patients with left versus right frontal-lobe lesions. Arch Clin Neuropsychol 9:41–55
Ryan C, Butters N (1986) Neuropsychology of alcoholism. In: Wedding D, Horton AM Jr, Webster JS (eds) The neuropsychology handbook. Springer, New York
Schmidt CJ (1987) Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs. Eur J Pharmacol 136:81–88
Schmidt CJ, Wu L, Lovenberg W (1986) Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analog. Eur J Pharmacol 124:175–178
Shelton MD, Parsons OA, Leber WR (1984) Verbal and visuospatial performance in male alcoholics: a test of the premature-aging hypothesis. J Consult Clin Psychol 52:200–206
Smith A (1982) Symbol digit modalities test (SDMT): manual (revised). Western Psychological Services, Los Angeles
Solowij N, Hall W, Lee N (1992) Recreational MDMA use in Sydney: a profile of “ecstasy” users and their experiences with the drug. Br J Addict 87:1161–1172
Stone DM, Stahl DS, Hanson GL, Gibb JW (1986) The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine on monoaminergic systems in the rat brain. Eur J Pharmacol 128:41–48
Sweeney JA, Meisel L, Walsh VL, Castro-vinci D (1989) Assessment of cognitive functioning in poly-substance abusers. J Clin Psychol 45:346–351
Talland GA (1965) Deranged memory. Academic, New York
Tarter RE (1976) Neuropsychological investigations of alcoholism. In: Goldstein G, Neuringer C (eds) Empirical studies of alcoholism. Ballinger, Cambridge, Mass.
Taylor EM (1959) Psychological appraisal of children with cerebral deficits. Harvard University Press, Cambridge, Mass.
Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology 167:85–96
Tucha O, Smely C, Lange KW (1999) Verbal and figural fluency in patients with mass lesions of the left or right frontal lobes. J Clin Exp Neuropsychol 21:229–236
Verkes RJ, Gijsman HJ, Pieters MSM, Schoemaker RC, de Visser S, Kuijpers M, Pennings EJM, de Bruin D, Van de Wijngaart G, Van Gerven JMA, Cohen AF (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153:196–202
Walsh KW (1985) Understanding brain damage. Churchill-Livingstone, Edinburgh
Wareing M, Fisk JE, Murphy PN (2000) Working memory deficits in current and previous users of MDMA (“ecstasy”). Br J Psychol 91:181–188
Washton AM, Stone NS (1984) The human cost of chronic cocaine use. Med Asp Hum Sex 18:36–44
Wechsler D (1987) Wechsler memory scale manual. Psychological Corporation, Tex.
Weingartner H, Galanter M, Lemberger L et al. (1972) Effect of marijuana and synthetic Δ9-THC on information processing. In: Proceedings of the 80th Annual Convention of the American Psychological Association, pp 813–814
Wilson MA, Ricaurte GA, Molliver ME (1989) Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylene amphetamine. Neuroscience 28:121–137
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yip, J.T.H., Lee, T.M.C. Effect of ecstasy use on neuropsychological function: a study in Hong Kong. Psychopharmacology 179, 620–628 (2005). https://doi.org/10.1007/s00213-004-2083-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-004-2083-4